Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1994-11-07
1996-03-12
Lovering, Richard D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514460, 536 175, 536 179, 549476, 549478, A61K 3170, C07H 1500
Patent
active
054987750
ABSTRACT:
This invention relates to the use of polyanionic benzylglycosides as smooth muscle cell proliferation inhibitors and as therapeutic compositions for treating diseases and conditions which are characterized by excessive smooth muscle proliferation, such as restenosis. The compounds of this invention are those of formula I ##STR1## wherein each of R.sup.1, R.sup.2, R.sup.3, and R.sup.4 are, independently, H, SO.sub.3 M, or ##STR2## and each oligosaccharide group contains 1 to 3 sugar groups; M is lithium, sodium, potassium, or ammonium;
n is 1 or 2;
X is a halogen, lower alkyl having 1 to 6 carbon atoms, or lower alkoxy having 1 to 6 carbon atoms;
Y is carbonyl or sulfonyl;
Z is alkyl from 1 to 12 carbon atoms, ##STR3## and X is as defined above; or a pharmaceutically acceptable salt thereof.
REFERENCES:
patent: 4431636 (1984-02-01), Schaub et al.
patent: 4431637 (1984-02-01), Upeslacis et al.
patent: 4431638 (1984-02-01), Schaub et al.
patent: 4435387 (1984-03-01), Schaub et al.
patent: 5019562 (1991-05-01), Folkman et al.
Clowes, et al., J. Vasc. Surg. 13, 885-891 (1991).
Raines et al., Br. Heart J. 69 (Suppl.), S30 (1993).
Isik et al., Am. J. Pathol., 141 (5) 1139-1149 (1992).
Herrmann et al., Drugs 46(1), 18-52 (1993).
Herrman et al., Drugs 46(1) 249-262 (1993).
Weissberg et al., Cardiovascular Res. 27 1191-1198 (1993).
Castellot et al., Seminars in Thrombosis and Hemostasis, 13(4), 489-503 (1987).
Borman, Chemical and Engineering News, p. 27, Jun. 28, 1993.
Reilly et al., Drug Development Research, 29, 137-147 (1993).
Casscells, Circulation, 86, 723-729 (1992).
Reidy et al., Endothelial Cell Dysfunction, 31-48, Ed. Plenum Press, NY (1992).
Wight, Arteriosclerosis 1989, 9, 1-20 (1989).
Schmid et al., Seminar in Thrombosis and Hemostasis, 19, Suppl. 1, 155-159 (1993).
Amann et al., Seminars in Thrombosis and Hemostasis, 19, Suppl. 1, 160-163 (1993).
Radhakrishnamurthy et al., Atherosclerosis, 60, 141-149 (1986).
Maffrand et al., Seminars in Thrombosis and Hemostasis, 17, Suppl. 2, 186-198 (1991).
Weisz et al., Angiogensis: Key Principle-Science-Technology-Medicine p. 107 (1992).
Hermann et al., Arteriosclerosis and Thrombosis, 13, 924-931 (1993).
Ellingboe John W.
Nguyen Thomas T.
Novak Sarah T. A.
Soll Richard M.
American Home Products Corporation
Eck Steven R.
Kilby Scalzo Catherine
Lovering Richard D.
LandOfFree
Polyanionic benzylglycosides as inhibitors of smooth muscle cell does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polyanionic benzylglycosides as inhibitors of smooth muscle cell, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polyanionic benzylglycosides as inhibitors of smooth muscle cell will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2101428